Air India Pilot Fails Drug Test After Mid-Air Altitude Drop

The captain of an Air India flight traveling from Phuket to Delhi tested positive for marijuana following a harrowing mid-air incident. Sources confirm the pilot failed two consecutive dope tests, including a confirmatory test, after the aircraft experienced a sudden 300-foot altitude drop. This rare flight-control event occurred during a scheduled operation on August 11, 2026, prompting immediate scrutiny from aviation regulators. The Directorate General of Civil Aviation (DGCA) has grounded the pilot as per standard safety protocols.

The Aircraft Accident Investigation Bureau (AAIB) has widened its probe into the flight-control failure that caused the sharp descent. Initial reports indicate the aircraft suffered a significant technical anomaly that led to the sudden loss of altitude, causing panic among passengers. Investigators are now examining whether the pilot's alleged substance use contributed to the handling of the emergency or if it was a purely mechanical failure. The presence of psychoactive substances in a cockpit crew member represents a critical violation of national aviation safety standards.

The incident has raised urgent questions regarding the efficacy of pre-flight and post-flight medical screenings in India. While routine alcohol breathalyzer tests are mandatory, comprehensive drug testing is typically conducted under specific circumstances or post-incident. This development is expected to trigger a nationwide audit of crew wellness and stricter enforcement of drug-free policies across all Indian carriers. For the average Indian traveler, this highlights a significant gap in safety oversight that the DGCA must address to maintain public confidence in air travel.